by creavo | Dec 20, 2018 | News
By Steve Parker, Chief Executive Officer It’s been an incredible year for Creavo, as we move ever closer to the commercialisation of Corsens®, the world’s first deployable MCG device with the potential to revolutionise the cardiac triage process, it is more important...
by creavo | Sep 5, 2018 | News
Creavo will be attending the EUSEM Congress in Glasgow, 8-12 September. We will be showcasing our new device on EUSEM exhibition stand 66. Having already received positive feedback at the European Society of Cardiology Congress in Munich, we are looking forward to...
by creavo | Aug 9, 2018 | News
Creavo Medical Technologies (Creavo) is pleased to announce the enrolment of the last patient in a study led by the cardiology team at the South Warwickshire NHS Foundation Trust. The study will assess if Creavo’s magnetocardiography (MCG) device can differentiate...
by creavo | Jul 19, 2018 | News, Press Release
A new cardiac diagnostic device aimed at helping physicians rule out active ischaemia in patients presenting to the emergency department (ED) with chest pain is being trialled at five of the most respected research facilities in the United States (Mayo Clinic,...
by creavo | Jul 5, 2018 | News
It all began in 1948 when Aneurin Bevan established the National Health Service based on the premise that good healthcare should be available to all, regardless of wealth. 70 years on and the NHS sees almost 1.5 million patients every day in England alone. It has...
